6.
Takagi J, Petre B, Walz T, Springer T
. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell. 2002; 110(5):599-11.
DOI: 10.1016/s0092-8674(02)00935-2.
View
7.
Nermut M, Green N, Eason P, Yamada S, Yamada K
. Electron microscopy and structural model of human fibronectin receptor. EMBO J. 1988; 7(13):4093-9.
PMC: 455118.
DOI: 10.1002/j.1460-2075.1988.tb03303.x.
View
8.
Engvall E, Ruoslahti E
. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer. 1977; 20(1):1-5.
DOI: 10.1002/ijc.2910200102.
View
9.
Lin F, Li J, Xie Y, Zhu J, Nguyen T, Zhang Y
. A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell. 2022; 185(19):3533-3550.e27.
PMC: 9494814.
DOI: 10.1016/j.cell.2022.08.008.
View
10.
Dehnadi A, Cosimi A, Smith R, Li X, Alonso J, Means T
. Prophylactic orthosteric inhibition of leukocyte integrin CD11b/CD18 prevents long-term fibrotic kidney failure in cynomolgus monkeys. Nat Commun. 2017; 8:13899.
PMC: 5234083.
DOI: 10.1038/ncomms13899.
View
11.
Dana N, Clayton L, Tennen D, Pierce M, LACHMANN P, Law S
. Leukocytes from four patients with complete or partial Leu-CAM deficiency contain the common beta-subunit precursor and beta-subunit messenger RNA. J Clin Invest. 1987; 79(3):1010-5.
PMC: 424264.
DOI: 10.1172/JCI112868.
View
12.
Adair B, Alonso J, Van Agthoven J, Hayes V, Ahn H, Yu I
. Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis. Nat Commun. 2020; 11(1):398.
PMC: 6972956.
DOI: 10.1038/s41467-019-13928-2.
View
13.
Dana N, Fathallah D, Arnaout M
. Expression of a soluble and functional form of the human beta 2 integrin CD11b/CD18. Proc Natl Acad Sci U S A. 1991; 88(8):3106-10.
PMC: 51394.
DOI: 10.1073/pnas.88.8.3106.
View
14.
Humphries M, Mould A
. Structure. An anthropomorphic integrin. Science. 2001; 294(5541):316-7.
DOI: 10.1126/science.1066240.
View
15.
Walbaum S, Ambrosy B, Schutz P, Bachg A, Horsthemke M, Leusen J
. Complement receptor 3 mediates both sinking phagocytosis and phagocytic cup formation via distinct mechanisms. J Biol Chem. 2021; 296:100256.
PMC: 7948798.
DOI: 10.1016/j.jbc.2021.100256.
View
16.
Phillips D, Jenkins C, LUSCHER E, Larrieu M
. Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature. 1975; 257(5527):599-600.
DOI: 10.1038/257599a0.
View
17.
Springer T, Galfre G, Secher D, Milstein C
. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol. 1979; 9(4):301-6.
DOI: 10.1002/eji.1830090410.
View
18.
Danilenko D, Rossitto P, Van der Vieren M, Le Trong H, McDonough S, Affolter V
. A novel canine leukointegrin, alpha d beta 2, is expressed by specific macrophage subpopulations in tissue and a minor CD8+ lymphocyte subpopulation in peripheral blood. J Immunol. 1995; 155(1):35-44.
View
19.
Todd 3rd R, Arnaout M, Rosin R, Crowley C, Peters W, Babior B
. Subcellular localization of the large subunit of Mo1 (Mo1 alpha; formerly gp 110), a surface glycoprotein associated with neutrophil adhesion. J Clin Invest. 1984; 74(4):1280-90.
PMC: 425295.
DOI: 10.1172/JCI111538.
View
20.
Kishimoto T, Hollander N, Roberts T, Anderson D, Springer T
. Heterogeneous mutations in the beta subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency. Cell. 1987; 50(2):193-202.
DOI: 10.1016/0092-8674(87)90215-7.
View